RNF113B Antibodies

Santa Cruz Biotechnology provides a broad selection of RNF113B monoclonal antibodies for research focused on understanding RNF113B's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RNF113B is a member of the RING finger protein family, which participates in ubiquitination processes that regulate protein degradation and cellular signaling pathways. RNF113B maintains cellular homeostasis through its involvement in cell cycle regulation and stress response mechanisms. Research has shown that RNF113B functions are significant in both normal cellular processes and disease development. Scientists worldwide utilize RNF113B monoclonal antibodies to investigate molecular pathways and cellular mechanisms. Ongoing studies of RNF113B continue to reveal new insights about its biological significance and potential therapeutic applications. Understanding RNF113B's role in cellular processes may lead to breakthroughs in disease treatment strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific knowledge and contribute to the development of new therapeutic approaches.